Brand K - Search Results

1

Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection.

Buttgereit P, Weineck S, Röpke G, Märten A, Brand K, Heinicke T, Caselmann WH, Huhn D, Schmidt-Wolf IG. Buttgereit P, et al. Among authors: brand k. Cancer Gene Ther. 2000 Aug;7(8):1145-55. doi: 10.1038/sj.cgt.7700209. Cancer Gene Ther. 2000. PMID: 10975675

2

Effects of adenoviral wild-type p53 gene transfer in p53-mutated lymphoma cells.

Buttgereit P, Schakowski F, Märten A, Brand K, Renoth S, Ziske C, Schöttker B, Ebert O, Schroers R, Schmidt-Wolf IG. Buttgereit P, et al. Among authors: brand k. Cancer Gene Ther. 2001 Jun;8(6):430-9. doi: 10.1038/sj.cgt.7700323. Cancer Gene Ther. 2001. PMID: 11498763

3

Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors.

Brand K, Arnold W, Bartels T, Lieber A, Kay MA, Strauss M, Dörken B. Brand K, et al. Cancer Gene Ther. 1997 Jan-Feb;4(1):9-16. Cancer Gene Ther. 1997. PMID: 9012446

4

Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach.

Brand K, Löser P, Arnold W, Bartels T, Strauss M. Brand K, et al. Gene Ther. 1998 Oct;5(10):1363-71. doi: 10.1038/sj.gt.3300728. Gene Ther. 1998. PMID: 9930342

5

Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection.

Brand K, Klocke R, Possling A, Paul D, Strauss M. Brand K, et al. Gene Ther. 1999 Jun;6(6):1054-63. doi: 10.1038/sj.gt.3300914. Gene Ther. 1999. PMID: 10455408

6

Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinases-1 in the liver: efficient protection against T-cell lymphoma and colon carcinoma metastasis.

Elezkurtaj S, Kopitz C, Baker AH, Perez-Cantó A, Arlt MJ, Khokha R, Gansbacher B, Anton M, Brand K, Krüger A. Elezkurtaj S, et al. Among authors: brand k. J Gene Med. 2004 Nov;6(11):1228-37. doi: 10.1002/jgm.637. J Gene Med. 2004. PMID: 15390257

7

Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue.

Brand K, Baker AH, Perez-Cantó A, Possling A, Sacharjat M, Geheeb M, Arnold W. Brand K, et al. Cancer Res. 2000 Oct 15;60(20):5723-30. Cancer Res. 2000. PMID: 11059766

8

Cancer gene therapy with tissue inhibitors of metalloproteinases (TIMPs).

Brand K. Brand K. Curr Gene Ther. 2002 May;2(2):255-71. doi: 10.2174/1566523024605564. Curr Gene Ther. 2002. PMID: 12109221 Review.

9

YB-1 relocates to the nucleus in adenovirus-infected cells and facilitates viral replication by inducing E2 gene expression through the E2 late promoter.

Holm PS, Bergmann S, Jurchott K, Lage H, Brand K, Ladhoff A, Mantwill K, Curiel DT, Dobbelstein M, Dietel M, Gansbacher B, Royer HD. Holm PS, et al. Among authors: brand k. J Biol Chem. 2002 Mar 22;277(12):10427-34. doi: 10.1074/jbc.M106955200. Epub 2002 Jan 11. J Biol Chem. 2002. PMID: 11788582 Free article.

10

Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling.

Kopitz C, Gerg M, Bandapalli OR, Ister D, Pennington CJ, Hauser S, Flechsig C, Krell HW, Antolovic D, Brew K, Nagase H, Stangl M, von Weyhern CW, Brücher BL, Brand K, Coussens LM, Edwards DR, Krüger A. Kopitz C, et al. Among authors: brand k. Cancer Res. 2007 Sep 15;67(18):8615-23. doi: 10.1158/0008-5472.CAN-07-0232. Cancer Res. 2007. PMID: 17875701 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

429 results

Search Page

Filters